Skip to main content

This job has expired

You will need to login before you can apply for a job.

Research Associate, Cancer Discovery

Employer
Omega Therapeutics
Location
Cambridge, MA
Start date
Oct 13, 2021

View more

Discipline
Regulatory, Science/R&D, Immunology, Oncology
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Genetown, NextGen Bio

Job Details

Omega Therapeutics is a development-stage biotechnology company pioneering a new class of programmable, mRNA-encoded therapeutics to transform human medicine. The OMEGA Epigenomic Programming™ platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cell genesis, growth and differentiation to cell death. The OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a normal range without altering native nucleic acid sequences. Omega’s engineered, modular, and programmable mRNA-encoded epigenetic medicines, Omega Epigenomic Controllers™, target specific intervention points amongst the thousands of validated novel DNA-sequence-based epigenomic targets we have mapped to tune single or multiple genes to treat and cure disease through Precision Genomic Control™. Omega is currently advancing a broad pipeline of development candidates spanning a range of disease areas, including oncology, regenerative medicine, multigenic diseases including immunology, and select monogenic diseases.

About the Role:

Omega Therapeutics, Inc. is seeking a Research Associate (RA) to join our cancer discovery team.  The successful candidate will assist in the development and advancement of our transcription modulation programs, from early development to proof-of-concept and beyond. The successful candidate must be a scientifically motivated self-starter, capable of working with minimal supervision, and conducting and critically analyzing experiments. The successful candidate will collaborate with senior project scientists and other research associates to design and complete in vitro proof-of-concept and in vivo translational studies on aggressive timelines.

We are looking for enthusiastic, detail oriented, and highly motivated individuals with a passion for bringing novel medicines to patients and who are comfortable working on a fast-paced scientific team.

Key Responsibilities:

  • Utilize a broad technical knowledge of cell and molecular biology tools to support platform build and therapeutic program development with a focus on genomic sequencing-based assays
  • Must be comfortable following developed protocols and should have a demonstrable ability to assist in developing new techniques and assays
  • Provide support for cell-based assays and optimization of new sequencing-based protocols
  • Assist in management of day-to-day laboratory operations including maintenance of equipment, as well as reagent tracking, ordering, and receiving

Required Skills:

  • Well versed in techniques that include but are not limited to mammalian cell culture, transfections, RNA/DNA/protein isolation and analysis, qPCR, gel electrophoresis, cell viability-based assays
  • Detail oriented and comfortable working with high-throughput assay formats
  • Working knowledge of chromatin and/or epigenetics
  • Previous experience in next-generation sequencing, ChIP, and bisulfite conversion techniques is a plus
  • Strong presentation and excellent communication skills, both oral and written, with diligent notetaking, ELN records and adherence to SOPs
  • Demonstrated ability in working with highly skilled teams in a fast paced, entrepreneurial and technical setting
  • Highly adaptable and responsive to technical and business opportunities - comfortable delivering against challenging project needs and timelines

 Required Qualifications:

  • Bachelor’s/Master’s Degree in Cell or Molecular Biology, Genetics, Cancer Biology or a related field

 

Company

Omega Therapeutics is a publicly held, development-stage biotechnology company pioneering a new class of DNA-sequence-targeting, mRNA-encoded therapeutics to transform human medicine. The OMEGA Epigenomic Programming™ platform harnesses the power of epigenetics, the mechanism that systematically controls every aspect of an organism’s life from cell genesis, to growth and differentiation. The OMEGA platform has identified thousands of novel DNA-sequence-based epigenomic targets within Insulated Genomic Domains (IGDs), referred to as EpiZips™. IGDs represent the three-dimensional, distinct, and evolutionarily conserved architecture of the genome, and are the fundamental structural and functional units of gene control and cell differentiation. They act as the “control room” of biology. The OMEGA platform examines alterations in IGDs leading to aberrant gene expression, a cause of most disease. It then leverages its database of EpiZips to identify appropriate intervention points within the IGDs and rationally designs biologically engineered, modular, and programmable mRNA-encoded epigenetic medicines, called Omega Epigenomic Controllers™, to target EpiZips for Precision Genomic Control™. With its computation- and data-first approach, Omega Therapeutics is currently advancing a broad pipeline of programs that span regenerative medicine, multigenic diseases including immunology, oncology, and select monogenic diseases.

Twitter

Company info
Website
Phone
(617) 949-4359
Location
140 First Street
Cambridge
MA
02141
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert